Use of Olanzapine in Anorexia Nervosa
J Clin Psychiatry 2005(5);66:654-655 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Barbarich et al.1
report the potential benefits of olanzapine
in treating anorexia nervosa. I disagree with their results
and conclusions for the following reasons.
The study’s small sample size of 17 patients, 12 of whom
completed the study, could result in a type II error. That 71% of
patients completed the study is not “noteworthy,” as the authors